Cargando…
Measuring serum matrix metalloproteinase-9 levels in peripheral blood after subarachnoid hemorrhage to predict cerebral vasospasm
PURPOSE: We aimed to investigate serum levels of matrix metalloproteinase-9 in both subarachnoid hemorrhage and control groups for prediction of cerebral vasospasm in this study. METHODS: Venous serum matrix metalloproteinase-9 levels were prospectively measured four times (days 1, 3, 7, and 14) for...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4958081/ https://www.ncbi.nlm.nih.gov/pubmed/27504251 http://dx.doi.org/10.1186/s40064-016-2837-6 |
_version_ | 1782444264984150016 |
---|---|
author | Akpinar, Aykut Ucler, Necati Erdogan, Uzay Baydin, Serhat S. Gungor, Abuzer Tugcu, Bekir |
author_facet | Akpinar, Aykut Ucler, Necati Erdogan, Uzay Baydin, Serhat S. Gungor, Abuzer Tugcu, Bekir |
author_sort | Akpinar, Aykut |
collection | PubMed |
description | PURPOSE: We aimed to investigate serum levels of matrix metalloproteinase-9 in both subarachnoid hemorrhage and control groups for prediction of cerebral vasospasm in this study. METHODS: Venous serum matrix metalloproteinase-9 levels were prospectively measured four times (days 1, 3, 7, and 14) for 34 consecutive patients with subarachnoidal hemorrhage (n = 27) and for elective aneurysm clipping (control, n = 7). RESULTS: Vasospasm developed in 11/34 (32.4 %) patients between 3 and 10 days after subarachnoid hemorrhage (median 5.58 days), mean peak serum matrix metalloproteinase-9 compared with the non-vasospasm cohort. Matrix metalloproteinase-9 levels were higher in subarachnoid hemorrhage patients than in the controls. CONCLUSION: Increased serum matrix metalloproteinase-9 could be an accurate biomarker to predict the onset of cerebral vasospasm after subarachnoid hemorrhage. |
format | Online Article Text |
id | pubmed-4958081 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-49580812016-08-08 Measuring serum matrix metalloproteinase-9 levels in peripheral blood after subarachnoid hemorrhage to predict cerebral vasospasm Akpinar, Aykut Ucler, Necati Erdogan, Uzay Baydin, Serhat S. Gungor, Abuzer Tugcu, Bekir Springerplus Research PURPOSE: We aimed to investigate serum levels of matrix metalloproteinase-9 in both subarachnoid hemorrhage and control groups for prediction of cerebral vasospasm in this study. METHODS: Venous serum matrix metalloproteinase-9 levels were prospectively measured four times (days 1, 3, 7, and 14) for 34 consecutive patients with subarachnoidal hemorrhage (n = 27) and for elective aneurysm clipping (control, n = 7). RESULTS: Vasospasm developed in 11/34 (32.4 %) patients between 3 and 10 days after subarachnoid hemorrhage (median 5.58 days), mean peak serum matrix metalloproteinase-9 compared with the non-vasospasm cohort. Matrix metalloproteinase-9 levels were higher in subarachnoid hemorrhage patients than in the controls. CONCLUSION: Increased serum matrix metalloproteinase-9 could be an accurate biomarker to predict the onset of cerebral vasospasm after subarachnoid hemorrhage. Springer International Publishing 2016-07-22 /pmc/articles/PMC4958081/ /pubmed/27504251 http://dx.doi.org/10.1186/s40064-016-2837-6 Text en © The Author(s) 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Research Akpinar, Aykut Ucler, Necati Erdogan, Uzay Baydin, Serhat S. Gungor, Abuzer Tugcu, Bekir Measuring serum matrix metalloproteinase-9 levels in peripheral blood after subarachnoid hemorrhage to predict cerebral vasospasm |
title | Measuring serum matrix metalloproteinase-9 levels in peripheral blood after subarachnoid hemorrhage to predict cerebral vasospasm |
title_full | Measuring serum matrix metalloproteinase-9 levels in peripheral blood after subarachnoid hemorrhage to predict cerebral vasospasm |
title_fullStr | Measuring serum matrix metalloproteinase-9 levels in peripheral blood after subarachnoid hemorrhage to predict cerebral vasospasm |
title_full_unstemmed | Measuring serum matrix metalloproteinase-9 levels in peripheral blood after subarachnoid hemorrhage to predict cerebral vasospasm |
title_short | Measuring serum matrix metalloproteinase-9 levels in peripheral blood after subarachnoid hemorrhage to predict cerebral vasospasm |
title_sort | measuring serum matrix metalloproteinase-9 levels in peripheral blood after subarachnoid hemorrhage to predict cerebral vasospasm |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4958081/ https://www.ncbi.nlm.nih.gov/pubmed/27504251 http://dx.doi.org/10.1186/s40064-016-2837-6 |
work_keys_str_mv | AT akpinaraykut measuringserummatrixmetalloproteinase9levelsinperipheralbloodaftersubarachnoidhemorrhagetopredictcerebralvasospasm AT uclernecati measuringserummatrixmetalloproteinase9levelsinperipheralbloodaftersubarachnoidhemorrhagetopredictcerebralvasospasm AT erdoganuzay measuringserummatrixmetalloproteinase9levelsinperipheralbloodaftersubarachnoidhemorrhagetopredictcerebralvasospasm AT baydinserhats measuringserummatrixmetalloproteinase9levelsinperipheralbloodaftersubarachnoidhemorrhagetopredictcerebralvasospasm AT gungorabuzer measuringserummatrixmetalloproteinase9levelsinperipheralbloodaftersubarachnoidhemorrhagetopredictcerebralvasospasm AT tugcubekir measuringserummatrixmetalloproteinase9levelsinperipheralbloodaftersubarachnoidhemorrhagetopredictcerebralvasospasm |